• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Esomeprazole Potassium

Esomeprazole Potassium

Product ID E7357
Cas No. 161796-84-5
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $97.70 In stock
25 mg $166.80 In stock
100 mg $469.10 In stock
500 mg $1,080.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Esomeprazole is the (S) isomer of omeprazole, a proton pump inhibitor. Esomeprazole inhibits the gastric H+/K+ ATPase, preventing H+ secretion. Esomeprazole is clinically used to treat ulcers and gastroesophageal reflux disease (GERD). Esomeprazole exhibits anti-ulcer and anticancer chemotherapeutic activities. In vitro, esomeprazole induces autophagy by decreasing mTOR activity and induces caspase-dependent apoptosis, killing melanoma cells. In animal models, esomeprazole increases gastric antioxidant capacity and superoxide dismutase (SOD) activity, exhibiting some antioxidative benefit. Esomeprazole also induces apoptosis in osteoclasts and osteoblasts, potentially decreasing bone turnover. Additionally, this compound inhibits monoamine oxidase (MAO-A and MAO-B).

Product Info

Cas No.

161796-84-5

Purity

≥98%

Formula

C17H18N3O3S K

Formula Wt.

383.51

Chemical Name

6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole

IUPAC Name

potassium;5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide

Synonym

Omeprazole potassium

Melting Point

155C

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

E7357 MSDS PDF

Info Sheet

E7357 Info Sheet PDF

References

Sugano K, Choi MG, Lin JT, et al. Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study. Gut. 2013 Dec 10. [Epub ahead of print]. PMID: 24326741.

Costa-Rodrigues J, Reis S, Teixeira S, et al. Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity. FEBS J. 2013 Oct;280(20):5052-64. PMID: 23937530.

Petzer A, Pienaar A, Petzer JP. The inhibition of monoamine oxidase by esomeprazole. Drug Res (Stuttg). 2013 Sep;63(9):462-7. PMID: 23677700.

Marino ML, Fais S, Djavaheri-Mergny M, et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis. 2010 Oct 21;1:e87. PMID: 21368860.

Saccar CL. The pharmacology of esomeprazole and its role in gastric acid related diseases. Expert Opin Drug Metab Toxicol. 2009 Sep;5(9):1113-24. PMID: 19606942.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T7134

    trans-3,4′,5-Trimethoxy Stilbene

    Resveratrol prodrug; potential SIRT1 activator....

    ≥99%
  • T1953

    Tenovin-3

    Potential p53 activator or SIRT2 inhibitor.

    ≥98%
  • F8147

    Fulvestrant

    Induces ER degradation.

    ≥98%
  • C0824

    CCG1423

    Serum response factor inhibitor and MRTF-A bind...

    ≥98%
  • G4596

    Glycidamide

    Epoxide metabolite of acrylamide, induces DNA a...

    ≥98%
  • A0916

    Acepromazine Maleate

    Phenothiazine derivative; D1/2 and 5-HT1A/2A an...

    ≥99%
  • F1607

    Febuxostat

    Xanthine oxidase inhibitor.

    ≥98%
  • S824766

    Sutezolid

    Bactericidal.

    ≥98%
  • F4680

    Flutamide

    Non-steroid; AR antagonist.

    ≥98%
  • T0299

    Tazobactam Sodium

    β-lactamase inhibitor.

    ≥98%
  • M1749

    Memantine Hydrochloride

    D2 agonist, NMDA, 5-HT3, α7 nAChR antagonist.<...

    ≥97%
  • S8248

    Sulfamethoxazole

    Sulfonamide; PABA inhibitor.

    ≥98%
  • N0068

    Naringenin

    Flavanone found in species of Citrus. Naringen...

    ≥98%
  • G0243

    (−)-Gallocatechin

    Polyphenol found in Camilla sinensis; HIV integ...

    ≥98%
  • V0244

    Valganciclovir Hydrochloride

    Nucleoside (deoxyguanosine) analog, ganciclovir...

    ≥98%
  • A2420

    A-769662

    AMPK activator.

    ≥98%
  • G5875

    Gossypol Acetic Acid

    Bcl-2, Bcl-xl, sialyl transferase inhibitor.

    ≥98%
  • G4532

    Gliclazide

    Sulfonylurea; SUR1 antagonist.

    ≥98%
  • G0175

    Gastric Inhibitory Peptide, human

    Endogenous peptide hormone, somatostatin analog...

    ≥95%
  • L0249

    Laminin Peptide YIGSR-NH2

    Laminin-derived peptapeptide.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only